509 related articles for article (PubMed ID: 22886480)
1. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.
Ito T; Igarashi H; Jensen RT
J Gastroenterol; 2012 Sep; 47(9):941-60. PubMed ID: 22886480
[TBL] [Abstract][Full Text] [Related]
2. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.
Grandhi MS; Lafaro KJ; Pawlik TM
J Gastrointest Surg; 2015 Dec; 19(12):2273-82. PubMed ID: 26341823
[TBL] [Abstract][Full Text] [Related]
3. Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.
Singh S; Dey C; Kennecke H; Kocha W; Maroun J; Metrakos P; Mukhtar T; Pasieka J; Rayson D; Rowsell C; Sideris L; Wong R; Law C
Ann Surg Oncol; 2015 Aug; 22(8):2685-99. PubMed ID: 25366583
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.
Ito T; Igarashi H; Jensen RT
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):737-53. PubMed ID: 23582916
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumors.
Perri G; Prakash LR; Katz MHG
Curr Opin Gastroenterol; 2019 Sep; 35(5):468-477. PubMed ID: 31306159
[TBL] [Abstract][Full Text] [Related]
6. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
Cloyd JM; Poultsides GA
World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
[TBL] [Abstract][Full Text] [Related]
7. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic neuroendocrine tumors: a review.
Young K; Iyer R; Morganstein D; Chau I; Cunningham D; Starling N
Future Oncol; 2015; 11(5):853-64. PubMed ID: 25757686
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors of the pancreas.
Milan SA; Yeo CJ
Curr Opin Oncol; 2012 Jan; 24(1):46-55. PubMed ID: 22080942
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for PNET liver metastases: a systematic review.
Nigri G; Petrucciani N; Debs T; Mangogna LM; Crovetto A; Moschetta G; Persechino R; Aurello P; Ramacciato G
World J Surg Oncol; 2018 Jul; 16(1):142. PubMed ID: 30007406
[TBL] [Abstract][Full Text] [Related]
11. Advances in the management of unresectable or metastatic pancreatic neuroendocrine tumors: chemotherapy, targeted therapy, hormonal treatment, and future directions.
Bilici A
Asian Pac J Cancer Prev; 2015; 16(6):2151-9. PubMed ID: 25824731
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic diagnosis and treatment of pancreatic neuroendocrine tumors.
Rustagi T; Farrell JJ
J Clin Gastroenterol; 2014; 48(10):837-44. PubMed ID: 24828360
[TBL] [Abstract][Full Text] [Related]
13. An update on the management of pancreatic neuroendocrine tumors.
Gao L; Natov NS; Daly KP; Masud F; Chaudhry S; Sterling MJ; Saif MW
Anticancer Drugs; 2018 Aug; 29(7):597-612. PubMed ID: 29782352
[TBL] [Abstract][Full Text] [Related]
14. Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.
Neychev V; Kebebew E
Int J Surg Oncol; 2017; 2017():6424812. PubMed ID: 28593056
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.
Ro C; Chai W; Yu VE; Yu R
Chin J Cancer; 2013 Jun; 32(6):312-24. PubMed ID: 23237225
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas.
Folkert IW; Hernandez P; Roses RE
World J Gastroenterol; 2016 Mar; 22(11):3105-16. PubMed ID: 27003988
[TBL] [Abstract][Full Text] [Related]
17. The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.
Krug S; Gress TM; Michl P; Rinke A
Digestion; 2017; 96(2):67-75. PubMed ID: 28728148
[TBL] [Abstract][Full Text] [Related]
18. Gastroenteropancreatic Neuroendocrine Tumors.
Cives M; Strosberg JR
CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
[TBL] [Abstract][Full Text] [Related]
19. Medical Management of Pancreatic Neuroendocrine Tumors: Current and Future Therapy.
Chan JA; Kulke MH
Surg Oncol Clin N Am; 2016 Apr; 25(2):423-37. PubMed ID: 27013373
[TBL] [Abstract][Full Text] [Related]
20. Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.
Yoo C; Oh CR; Kim ST; Bae WK; Choi HJ; Oh DY; Lee MA; Ryoo BY
Cancer Res Treat; 2021 Apr; 53(2):291-300. PubMed ID: 33421978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]